# Pentoxifylline in Patients With Ulcerative Colitis

> **NCT07349472** · PHASE2 · RECRUITING · sponsor: **Ihab Elsayed Hassan** · enrollment: 60 (estimated)

## Conditions studied

- Inflammatory Bowel Diseases

## Interventions

- **DRUG:** Mesalamine
- **DRUG:** Pentoxifylline

## Key facts

- **NCT ID:** NCT07349472
- **Lead sponsor:** Ihab Elsayed Hassan
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-20
- **Primary completion:** 2027-01-20
- **Final completion:** 2027-02-20
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07349472

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07349472, "Pentoxifylline in Patients With Ulcerative Colitis". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07349472. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*